NCT03747900View on ClinicalTrials.gov

Dry Needling and Botulinum Toxin in the Management of Poststroke Spasticity

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 11, 2017

Primary Completion Date

March 30, 2018

Study Completion Date

March 30, 2018

Conditions
Spasticity, Muscle
Interventions
DRUG

Botulinum Toxin Type A

200 U Botulinum toxin type A injection in the spastic biceps brachii muscle.

COMBINATION_PRODUCT

Botulinum Toxin Type A and dry needling.

Dry needling for 4 times in total in the spastic biceps brachii muscle after the Botulinum toxin type A injection.

Trial Locations (1)

34668

Sultan Abdulhamid Han Training and Research Hospital, Istanbul

All Listed Sponsors
lead

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

OTHER

NCT03747900 - Dry Needling and Botulinum Toxin in the Management of Poststroke Spasticity | Biotech Hunter | Biotech Hunter